These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17055123)

  • 1. Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups.
    Chua BY; Zeng W; Lau YF; Jackson DC
    Vaccine; 2007 Jan; 25(1):92-101. PubMed ID: 17055123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of toll-like receptor-2 targeting lipopeptides as self-adjuvanting vaccines.
    Chua BY; Zeng W; Jackson DC
    Methods Mol Biol; 2008; 494():247-61. PubMed ID: 18726578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.
    Zeng W; Ghosh S; Lau YF; Brown LE; Jackson DC
    J Immunol; 2002 Nov; 169(9):4905-12. PubMed ID: 12391202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of the antibody response to a totally synthetic immunocontraceptive peptide vaccine based on LHRH.
    Zeng W; Gauci S; Ghosh S; Walker J; Jackson DC
    Vaccine; 2005 Aug; 23(35):4427-35. PubMed ID: 15919140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines.
    Lau YF; Deliyannis G; Zeng W; Mansell A; Jackson DC; Brown LE
    Int Immunol; 2006 Dec; 18(12):1801-13. PubMed ID: 17077175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity.
    Zhu X; Ramos TV; Gras-Masse H; Kaplan BE; BenMohamed L
    Eur J Immunol; 2004 Nov; 34(11):3102-14. PubMed ID: 15368273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of dominant epitopes of synthetic immunocontraceptive vaccines that induce antibodies in dogs.
    Yu M; Zeng W; Pagnon J; Walker J; Ghosh S; Wang LF; Jackson DC
    Vaccine; 2005 Aug; 23(37):4589-97. PubMed ID: 15927323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Totally synthetic peptide-based immunocontraceptive vaccines show activity in dogs of different breeds.
    Walker J; Ghosh S; Pagnon J; Colantoni C; Newbold A; Zeng W; Jackson DC
    Vaccine; 2007 Oct; 25(41):7111-9. PubMed ID: 17825958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulants and Toll-like receptor ligands obtained by screening combinatorial lipopeptide collections.
    Reutter F; Jung G; Baier W; Treyer B; Bessler WG; Wiesmüller KH
    J Pept Res; 2005 Mar; 65(3):375-83. PubMed ID: 15787968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes.
    Roth A; Espuelas S; Thumann C; Frisch B; Schuber F
    Bioconjug Chem; 2004; 15(3):541-53. PubMed ID: 15149182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of castration by immunization of male dogs with recombinant gonadotropin-releasing hormone (GnRH)-canine distemper virus (CDV) T helper cell epitope p35.
    Jung MJ; Moon YC; Cho IH; Yeh JY; Kim SE; Chang WS; Park SY; Song CS; Kim HY; Park KK; McOrist S; Choi IS; Lee JB
    J Vet Sci; 2005 Mar; 6(1):21-4. PubMed ID: 15785119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic lipopeptide adjuvants and Toll-like receptor 2--structure-activity relationships.
    Spohn R; Buwitt-Beckmann U; Brock R; Jung G; Ulmer AJ; Wiesmüller KH
    Vaccine; 2004 Jun; 22(19):2494-9. PubMed ID: 15193414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal vaccination with a lipopeptide containing a conformationally constrained conserved minimal peptide, a universal T cell epitope, and a self-adjuvanting lipid protects mice from group A streptococcus challenge and reduces throat colonization.
    Batzloff MR; Hartas J; Zeng W; Jackson DC; Good MF
    J Infect Dis; 2006 Aug; 194(3):325-30. PubMed ID: 16826480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma-derived lipopeptides: influence of lipid modification on the conformation and the ability to induce MHC class II expression on murine and human cells.
    Thiam K; Loing E; Verwaerde C; Auriault C; Gras-Masse H
    J Med Chem; 1999 Sep; 42(18):3732-6. PubMed ID: 10479305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocyte response induced by an improved synthetic lipopeptide vaccine against cervical cancer.
    Xu DH; Zhou CH; Xia YP; Qiu ZY; Wu YZ; Jia ZC; Zhou W
    Acta Pharmacol Sin; 2007 May; 28(5):695-702. PubMed ID: 17439726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triacylated lipoproteins derived from Mycoplasma pneumoniae activate nuclear factor-kappaB through toll-like receptors 1 and 2.
    Shimizu T; Kida Y; Kuwano K
    Immunology; 2007 Aug; 121(4):473-83. PubMed ID: 17433078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.
    Lombardi V; Van Overtvelt L; Horiot S; Moussu H; Chabre H; Louise A; Balazuc AM; Mascarell L; Moingeon P
    Clin Exp Allergy; 2008 Nov; 38(11):1819-29. PubMed ID: 18644025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-terminal pentapeptide of LHRH is a dominant B cell epitope with antigenic and biological function.
    Zeng W; Pagnon J; Jackson DC
    Mol Immunol; 2007 Jul; 44(15):3724-31. PubMed ID: 17512595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant.
    Jinshu X; Jingjing L; Duan P; Zheng Z; Ding M; Jie W; Rongyue C; Zhuoyi H; Roque RS
    Vaccine; 2005 Sep; 23(40):4834-43. PubMed ID: 15996796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.